These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6747662)

  • 1. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle.
    Delaporte C; Dehaupas M; Fardeau M
    J Neurol Sci; 1984 May; 64(2):149-60. PubMed ID: 6747662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective myoblasts identified in Duchenne muscular dystrophy.
    Blau HM; Webster C; Pavlath GK
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4856-60. PubMed ID: 6576361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal growth kinetics and 5'-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy.
    Liechti-Gallati S; Moser H; Siegrist HP; Wiesmann U; Herschkowitz NN
    Pediatr Res; 1981 Nov; 15(11):1411-4. PubMed ID: 6272184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy.
    Jasmin G; Tautu C; Vanasse M; Brochu P; Simoneau R
    Lab Invest; 1984 Feb; 50(2):197-207. PubMed ID: 6694359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy.
    Webster C; Blau HM
    Somat Cell Mol Genet; 1990 Nov; 16(6):557-65. PubMed ID: 2267630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased acetylcholine sensitivity in Duchenne muscular dystrophy myotubes.
    Meola G; Mancinelli E; Geremia L; Scarlato G
    Ital J Neurol Sci; 1991 Apr; 12(2):181-5. PubMed ID: 2071364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients.
    Miranda AF; Bonilla E; Martucci G; Moraes CT; Hays AP; Dimauro S
    Am J Pathol; 1988 Sep; 132(3):410-6. PubMed ID: 3046367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of alterations of skeletal muscle in Duchenne muscular dystrophy and polymyositis.
    Morizumi H; Hizawa K; Nunomura S; Ii K
    Acta Pathol Jpn; 1984 Nov; 34(6):1221-42. PubMed ID: 6524375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics.
    Wertz RL; Hartwig GB; Frost AP; Brophy JJ; Atwater SK; Roses AD
    J Cell Physiol; 1981 May; 107(2):255-60. PubMed ID: 7251683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation properties of pure populations of human dystrophic muscle cells.
    Blau HM; Webster C; Chiu CP; Guttman S; Chandler F
    Exp Cell Res; 1983 Apr; 144(2):495-503. PubMed ID: 6840225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collagen synthesis in cultured myoblasts and myotubes from patients with Duchenne muscular dystrophy.
    de Jong L; Wolterman RA; Hillarius S; Bolhuis PA
    J Neurol Sci; 1987 Dec; 82(1-3):271-80. PubMed ID: 3440869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis and muscle differentiation in a girl with severe muscular dystrophy.
    Meola G; Scarpini E; Velicogna M; Scarlato G; Larizza L; Conti AF
    J Neurol; 1986 Jun; 233(3):168-70. PubMed ID: 3723154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in surface morphology and basal lamina of cultured muscle cells from Duchenne muscular dystrophy patients.
    Delaporte C; Dautreaux B; Rouche A; Fardeau M
    J Neurol Sci; 1990 Jan; 95(1):77-88. PubMed ID: 2338566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.
    Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E
    Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy.
    Oexle K; Zwirner A; Freudenberg K; Kohlschütter A; Speer A
    Pediatr Res; 1997 Aug; 42(2):226-31. PubMed ID: 9262227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective growth in vitro of Duchenne Muscular Dystrophy myoblasts: the molecular and biochemical basis.
    Melone MA; Peluso G; Petillo O; Galderisi U; Cotrufo R
    J Cell Biochem; 1999 Nov; 76(1):118-32. PubMed ID: 10581006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle fibre size and shape in Duchenne muscular dystrophy.
    Watkins SC; Cullen MJ
    Neuropathol Appl Neurobiol; 1982; 8(1):11-7. PubMed ID: 7070584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tetrodotoxin- and Mn2(+)-insensitive Na+ current in Duchenne muscular dystrophy.
    Bkaily G; Jasmin G; Tautu C; Prochek L; Yamamoto T; Sculptoreanu A; Peyrow M; Jacques D
    Muscle Nerve; 1990 Oct; 13(10):939-48. PubMed ID: 2172811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.